Viagra Prescribing Will Be Based On Financial Rather Than Clinical Reasoning

January 29, 1999

(Viagra: a botched test case for rationing. If it leads to a proper debate over rationing the decision on sildenafil will not be all bad)

The secretary of state's proposals for the introduction of sildenafil (Viagra) may be rationing but they are not rational, says Dr John Chisholm in an editorial in this week's BMJ. In dressing up a rationing decision as a clinical one, the secretary of state has ended up with the worst of all possible worlds: a decision that makes no sense on clinical, equity or cost-effectiveness grounds. After months of uncertainty over how sildenafil would be made available on the NHS, Dr Chisholm suggests that these proposals may lead to a long-awaited public debate about NHS rationing.

The secretary of state has effectively admitted that the government can no longer fund an NHS according to its founding principles of comprehensiveness, universality and access based on need, but has made a decision that will at least ensure consistent access across the UK. Although the BMA has campaigned vigorously for increased NHS funding, it has also stated that if the government and taxpayers do not provide these financial resources, the government should explicitly state what the NHS can and cannot provide, rather than "leaving such decisions to individual doctors or to the accident of where patients live".

Contact:

Dr John Chisholm, Chairman General Practitioners Committee, via the BMA Press Office pressoffice@bma.org.uk
-end-


BMJ

Related Sildenafil Articles from Brightsurf:

Seeing blue after the little blue pill: Visual disturbances in Viagra users
Sildenafil, a common treatment for erectile dysfunction, is typically safe with limited side effects.

Long term risks cast further doubt on the use of Viagra for foetal therapy
University of Manchester scientists investigating a possible treatment for foetal growth restriction (FGR), a condition in which babies grow poorly in the womb, have urged further caution on the use of Viagra.

All roads lead to migraine
Dr. Samaira Younis, from the Danish Headache Center in Copenhagen, Denmark, shares her research results, which suggests there are no differences between migraine attacks clinical characteristics following administration of 2 different compounds in patients, CGRP and sildenafil, meaning they share common cellular signaling pathways.

Preeclampsia treatment for mothers also benefits offspring
An estimated six to 15 million people in the US are children born of a pregnancy complicated by preeclampsia.

New discovery provides key to side effects caused by erectile dysfunction drugs
Study reveals several features of PDE6 that were previously unseen.

A new approach to automation of chemical synthesis
Researchers have used a robotic platform to produce -- with no physical intervention -- three pharmaceutical compounds with yields and purities comparable to those achieved by manual efforts, they say.

Breakthrough for treatment of fibrotic diseases
A drug combination has potential to halt a process responsible for large numbers of deaths.

Irreversible damage to color vision linked to popular erectile dysfunction drug
In a first-of-its-kind study, Mount Sinai researchers have shown that color vision problems caused by retinal damage on a cellular level can result from a high dose of sildenafil citrate, the popular erectile-dysfunction medication sold under the brand name Viagra.

Study reveals Viagra to be 'ineffective' for fetal growth restriction
A University of Liverpool led international clinical trial has found an anti-impotence drug to be ineffective at improving outcomes for pregnancies complicated by fetal growth restriction.

Sildenafil should be avoided in valve disease with residual pulmonary hypertension
Sildenafil should not be used to treat residual hypertension in patients with valvular heart disease, according to late-breaking results from the SIOVAC trial presented today in a Hot Line LBCT Session at ESC Congress.

Read More: Sildenafil News and Sildenafil Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.